Sign In

What's New

Apr 28
The U.S. Food and Drug Administration has expanded the approved use of Stivarga (regorafinib) to include treatment of patients with hepatocellular carcinoma (HCC or liver cancer) who have been...
Apr 27
A diet high in fructose-containing sugars eaten during pregnancy or while breastfeeding can cause offspring to have a fatty liver, increasing their chances of developing obesity or type 2 diabetes.
Apr 25
A phase III trial of selective internal radiation therapy for hepatocellular carcinoma has found the treatment is safer and just as effective as sorafenib.

Member Spotlight

Roshan Shrestha, MD

I am the Medical Director of Liver Transplantation and a Clinical Professor of Medicine at Mercer University School of Medicine, and Piedmont Hospital in Atlanta.